Voyager Therapeutics (VYGR) Other Working Capital Changes (2014 - 2026)

Voyager Therapeutics (VYGR) has 11 years of Other Working Capital Changes data on file, last reported at -$1.2 million in Q1 2026.

• For the quarter ending Q1 2026, Other Working Capital Changes rose 73.69% year-over-year to -$1.2 million; the trailing twelve-month figure through Mar 2026 stood at -$3.9 million (up 89.98% YoY), and the FY2025 full-year result was -$7.2 million, up 83.88% from the prior year.
• Other Working Capital Changes grew to -$1.2 million in Q1 2026, from -$1.9 million in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $2.7 million in Q2 2025 to a low of -$3.2 million in Q3 2025.
• A 5-year average of $25294.1 and a median of -$191000.0 in 2022 frame the typical range for Other Working Capital Changes.
• Across the five-year window, Other Working Capital Changes soared 3196.54% in 2022 and plunged 5802.05% in 2024, its largest moves.
• Tracing VYGR's Other Working Capital Changes over 5 years: stood at -$3.8 million in 2022, then surged by 80.62% to -$731000.0 in 2023, then sank by 5802.05% to -$43.1 million in 2024, then jumped by 95.67% to -$1.9 million in 2025, then surged by 36.06% to -$1.2 million in 2026.
• Business Quant data shows VYGR's Other Working Capital Changes at -$1.2 million in Q1 2026, -$1.9 million in Q4 2025, and $1.9 million in Q3 2025.